82 results on '"Benjamin Krämer"'
Search Results
2. Stop studying 'fake news' (we can still fight against disinformation in the media)
- Author
-
Benjamin Krämer
- Subjects
Linguistics and Language ,Sociology and Political Science ,business.industry ,Communication ,Political science ,Internet privacy ,Disinformation ,Fake news ,business ,Language and Linguistics - Abstract
The problem of “fake news” has received considerable attention both in public discourse and in scholarship. However, many have argued that the term should be avoided for ideological reasons or because it lacks clarity. At the same time, a growing body of literature investigates “fake news” empirically. We complement this discussion by reflecting on epistemological and methodological problems with the term “fake news” and the implications for possible solutions to the problem of disinformation such as automatic detection and increased media literacy. Based on the principle of symmetry established in the sociology of scientific knowledge, we show that a classification of messages according to the researcher’s assessment of their truthfulness can lead to biased or tautological explanations. We argue that many researchers commit themselves to the truth or falsehood of messages in cases where they should not and avoid such a commitment when it is necessary.
- Published
- 2021
- Full Text
- View/download PDF
3. TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
- Author
-
Leona Dold, K. Ommer, Benjamin Krämer, Christoph Boesecke, J. K. Rockstroh, L. Zimmer, Jacob Nattermann, C. Schwarze-Zander, Bettina Langhans, Christian P. Strassburg, J. C. Wasmuth, B. Gathof, Ulrich Spengler, and Raphael Mohr
- Subjects
Lipopolysaccharides ,Male ,T-Lymphocytes ,HIV Infections ,Monocytes ,0302 clinical medicine ,Bacterial infections ,Drug Discovery ,Cytotoxic T cell ,030212 general & internal medicine ,Genetics (clinical) ,Host factor ,Aged, 80 and over ,0303 health sciences ,Toll-Like Receptors ,Middle Aged ,Killer Cells, Natural ,medicine.anatomical_structure ,Oligodeoxyribonucleotides ,Cytokines ,Molecular Medicine ,Female ,Original Article ,Inflammatory immune response ,Adult ,HLA-B*57 ,CD14 ,T cell ,cART ,CD16 ,Sepsis ,Lipopeptides ,Young Adult ,03 medical and health sciences ,medicine ,Humans ,Aged ,030304 developmental biology ,Inflammation ,Innate immune system ,business.industry ,Monocyte ,HIV ,medicine.disease ,Immunity, Innate ,Toll-like receptor stimulation ,HLA-B Antigens ,Toll-Like Receptor 9 ,Immunology ,business - Abstract
Abstract HLA-B*57 affects the course of HIV infection. Under antiretroviral therapy, its effects cannot be explained by outstandingly efficient T cell responses alone but may also involve cells of innate immunity. Studying in vitro stimulation with Pam3CSK4, E. coli LPS-B5 and CpG-ODN-2216, we observed greater induction of IL-6/IL-1beta double-positive CD14+CD16++ monocytes as well as IFN-gamma-positive cytotoxic CD56highCD16neg NK cells in HLA-B*57- versus HLA-B*44-positive HIV patients, while TNF-alpha induction remained unchanged. Differences were not seen in the other monocyte and NK cell subsets or in HLA-matched healthy controls. Our findings show that, in virally suppressed HIV infection, HLA-B*57 is associated with enhanced responsiveness of inflammatory innate immune cells to TLR ligands, possibly contributing to increased vulnerability in sepsis. Key messages • HLA-B*57 is a host factor affecting clinical outcomes of HIV infection. • HLA-B*57 modifies inflammatory subsets of NK cells and monocytes in HIV infection. • In HLA-B*57-positive HIV patients TLR agonists induce enhanced IL-6/IL-1beta in monocytes. • NK cells from HLA-B*57 HIV patients release more IFN-gamma upon TLR costimulation. • HLA-B*57 is linked to enhanced inflammatory responsiveness to TLR ligands.
- Published
- 2020
- Full Text
- View/download PDF
4. Exemplification Effects: A Meta-Analysis
- Author
-
Christina Peter and Benjamin Krämer
- Subjects
Linguistics and Language ,business.industry ,Communication ,media_common.quotation_subject ,05 social sciences ,050801 communication & media studies ,Public opinion ,Highly selective ,0506 political science ,Exemplification ,Presentation ,0508 media and communications ,Anthropology ,Perception ,Meta-analysis ,050602 political science & public administration ,Developmental and Educational Psychology ,Journalism ,business ,Robustness (economics) ,Psychology ,media_common ,Cognitive psychology - Abstract
The presentation of single cases as examples for larger phenomena has a long-standing tradition in journalism. However, their usage has been viewed rather critically within the scientific community, because they are employed in a highly selective manner. Consequently, over the course of the last three decades, communication scholars from different research traditions have concerned themselves with the question of how single-case information within media content affects audience judgments. Although most publications report exemplification effects of some sort, it remains unclear which types of exemplars are effective and whether they are capable of influencing both perceptual and personal judgments. Applying a multi-level meta-regression approach, we synthesize findings across different studies and investigate potential moderators. Our results suggest overall exemplification effects that seem to be most pronounced for first-level reality judgments, such as public opinion or frequency estimates, but that are limited in their robustness when controlling for interdependence of the measurements.
- Published
- 2020
- Full Text
- View/download PDF
5. Ontology of opposition online. Representing antagonistic structures on the Internet
- Author
-
Benjamin Krämer and Nina Springer
- Subjects
World Wide Web ,Linguistics and Language ,Sociology and Political Science ,business.industry ,Computer science ,Communication ,Opposition (politics) ,The Internet ,business ,lcsh:P87-96 ,Language and Linguistics ,lcsh:Communication. Mass media - Abstract
Research on cooperative social structures and particular types of conflict behavior online is readily available. However, the field lacks a framework to analyze how antagonistic structures are represented on online platforms. Social structures can be represented formally (manifestly) or informally (in open verbal or visual forms) or remain latent - a distinction that has received little scholarly attention in the analysis of computermediated communication. Based on an interpretative analysis of relational structures and types of acts, we distinguish structural elements that lead us to empirical typologies of antagonistic structures and an analysis of whether and how they are represented online. We develop theses about why some structures are formally represented more often than others and theorize the consequences of this selective representation.
- Published
- 2020
- Full Text
- View/download PDF
6. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
- Author
-
Jacob Nattermann, Bettina Langhans, Leona Dold, Marieta Toma, Raphael Mohr, Philipp Lutz, Annabelle Vogt, Anna Maria Eis-Hübinger, Benjamin Krämer, Christian P. Strassburg, Maria A. Gonzalez-Carmona, Ulrich Spengler, and Hans Dieter Nischalke
- Subjects
Adult ,Cytotoxicity, Immunologic ,Male ,Cancer Research ,Carcinoma, Hepatocellular ,Programmed Cell Death 1 Receptor ,Immunology ,chemical and pharmacologic phenomena ,CD8-Positive T-Lymphocytes ,Lymphocyte Activation ,T-Lymphocytes, Regulatory ,B7-H1 Antigen ,Flow cytometry ,Interferon-gamma ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Immune Tolerance ,Humans ,Immunology and Allergy ,Medicine ,IL-2 receptor ,Cytotoxicity ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,biology ,business.industry ,Effector ,Liver Neoplasms ,Antibodies, Monoclonal ,FOXP3 ,hemic and immune systems ,Middle Aged ,Immune checkpoint ,Oncology ,Cancer research ,biology.protein ,Female ,Immunotherapy ,Antibody ,business ,CD8 ,030215 immunology - Abstract
Immune checkpoint inhibition suggests promising progress for the treatment of advanced hepatocellular carcinoma (HCC). However, the underlying cellular mechanisms remain unclear because liver cancer cells apparently do not upregulate inhibitory checkpoint molecules. Here, we analysed whether regulatory T cells (Tregs) can alternatively trigger checkpoint inhibition pathways in HCC. Using flow cytometry we analysed expression of checkpoint molecules (PD-1, PD-L1, CTLA-4, GITR, Tim-3) on peripheral CD4+CD25+Foxp3+ Tregs and their secretion of inhibitory mediators (IL-10, IL-35, TGF-beta, galectin-9) in 116 individuals (50 patients with HCC, 41 non-tumour bearing liver disease controls, 25 healthy controls). Functional activity of Tregs on T effector cells (IFN-gamma production, cytotoxicity) was characterized in vitro using a lectin-dependent cellular cytotoxicity (LDCC) assay against checkpoint inhibitor-negative P815 target cells. Unlike liver patients without malignancy and healthy controls, the frequency of checkpoint inhibitor-positive Tregs inversely correlated to age of patients with HCC (PD-L1, p = 0.0080; CTLA-4, p = 0.0029) and corresponded to enhanced numbers of Tregs producing IL-10 and IL-35 (p
- Published
- 2019
- Full Text
- View/download PDF
7. A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitis
- Author
-
Benjamin Krämer, Madlen Matz-Soja, Felix Goeser, Felix Stickel, Janett Fischer, Hans Dieter Nischalke, Christian P. Strassburg, Bettina Langhans, Philipp Lutz, Jacob Nattermann, Ulrich Spengler, Thomas Berg, Alexandra Klüners, and Michael Soyka
- Subjects
Liver Cirrhosis ,medicine.medical_specialty ,Alcoholic liver disease ,Cirrhosis ,Carcinoma, Hepatocellular ,Gastroenterology ,Polymorphism, Single Nucleotide ,03 medical and health sciences ,Liver disease ,0302 clinical medicine ,Non-alcoholic Fatty Liver Disease ,Internal medicine ,Genotype ,Medicine ,Humans ,Genetic Predisposition to Disease ,Risk factor ,Hepatology ,business.industry ,Liver Neoplasms ,medicine.disease ,digestive system diseases ,Toll-Like Receptor 5 ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Cohort ,030211 gastroenterology & hepatology ,Steatohepatitis ,business - Abstract
BACKGROUND & AIMS Bacterial translocation drives liver disease progression. We investigated whether functional genetic variants in toll-like receptor 5 (TLR5), the receptor for bacterial flagellin, affect the risk for hepatocellular carcinoma (HCC). METHODS Healthy controls (n = 212), patients with alcohol abuse without liver disease (n = 382), and patients from a discovery cohort of alcohol-associated cirrhosis (n = 372 including 79 HCC cases), a validation cohort of alcohol-associated cirrhosis (n = 355 including 132 HCC cases), and a cohort of cirrhosis due to nonalcoholic steatohepatitis (NASH) (n = 145 including 62 HCC cases) were genotyped for the TLR5 rs5744174 and rs5744168 polymorphisms. Chemokine levels were measured by ELISA in patients' sera and supernatants of flagellin-stimulated healthy monocytes. RESULTS Frequency of the TLR5 rs5744174 TT genotype was similar in healthy controls (33%), controls with alcohol abuse (34%), and patients with alcohol-associated cirrhosis in the discovery (28%), validation (33%), and NASH cohort (31%). The TT genotype was enriched in patients with versus without HCC in the discovery, validation, and NASH cohort (41% vs 25%; 39% vs 29%; 40% vs 24%; p
- Published
- 2021
8. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
- Author
-
Jacob Nattermann, Benjamin Krämer, Nikolaos Antonakos, Kristian Händler, Martina van Uelft, Matthijs Kox, Rainer Knoll, Lorenzo Bonaguro, Monique M.B. Breteler, Jonas Schulte-Schrepping, Marie Oestreich, Melanie Nuesch-Germano, Kevin Baßler, Niklas Bruse, Matthias Becker, Valentina Talevi, Nikoletta Rovina, Mihai G. Netea, Michael ToVinh, Maria Mouktaroudi, Theodore S. Kapellos, Antonia Koutsoukou, Lea Seep, Thomas Ulas, Maria Saridaki, Elena De Domenico, Frank L. van de Veerdonk, Jan Raabe, Ioanna D. Gemünd, Konstantina Gkizeli, Michael Kraut, N. Ahmad Aziz, Joachim L. Schultze, Heidi Theis, Verena Keitel, German Covid Omics Initiative, Peter Pickkers, Nico Reusch, Miriam Herbert, Charlotte Kröger, Shobhit Agrawal, Gereon Rieke, Evangelos J. Giamarellos-Bourboulis, Lena Lenkeit, Jelle Gerretsen, Anna C. Aschenbrenner, Sarandia Doulou, Kilian Dahm, Arik Horne, Christoph Hoffmeister, Lisa Holsten, Simachew Mengiste, Anna Drews, Jannik Gierlich, and Tal Pecht
- Subjects
business.industry ,Granulocyte ,Asymptomatic ,Transcriptome ,Immune system ,medicine.anatomical_structure ,Respiratory failure ,Cohort ,Immunology ,medicine ,medicine.symptom ,business ,Respiratory tract ,Whole blood - Abstract
SUMMARYThe SARS-CoV-2 pandemic is currently leading to increasing numbers of COVID-19 patients all over the world. Clinical presentations range from asymptomatic, mild respiratory tract infection, to severe cases with acute respiratory distress syndrome, respiratory failure, and death. Reports on a dysregulated immune system in the severe cases calls for a better characterization and understanding of the changes in the immune system. Here, we profiled whole blood transcriptomes of 39 COVID-19 patients and 10 control donors enabling a data-driven stratification based on molecular phenotype. Neutrophil activation-associated signatures were prominently enriched in severe patient groups, which was corroborated in whole blood transcriptomes from an independent second cohort of 30 as well as in granulocyte samples from a third cohort of 11 COVID-19 patients. Comparison of COVID-19 blood transcriptomes with those of a collection of over 2,800 samples derived from 11 different viral infections, inflammatory diseases and independent control samples revealed highly specific transcriptome signatures for COVID-19. Further, stratified transcriptomes predicted patient subgroup-specific drug candidates targeting the dysregulated systemic immune response of the host.
- Published
- 2020
- Full Text
- View/download PDF
9. Neither black nor white: do altered intestinal microbiota reflect chronic liver disease severity?
- Author
-
Alice C. McHardy, Till Robin Lesker, Philipp Lutz, Benjamin Krämer, Felix Goeser, Philipp C. Münch, Isabelle Bekeredjian-Ding, Christian P. Strassburg, Marijo Parcina, DJ Kaczmarek, Robert Geffers, Achim Hoerauf, Jacob Nattermann, C Finnemann, Ulrich Spengler, Hans Dieter Nischalke, and HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
- Subjects
0301 basic medicine ,Klebsiella ,medicine.medical_specialty ,medicine.drug_class ,liver cirrhosis ,Antibiotics ,Veillonella ,intestinal microbiology ,Autoimmune hepatitis ,Chronic liver disease ,medicine.disease_cause ,Gastroenterology ,Severity of Illness Index ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Lactobacillus ,medicine ,Humans ,hepatic fibrosis ,biology ,business.industry ,Streptococcus ,Liver Diseases ,chronic liver disease ,respiratory system ,biology.organism_classification ,medicine.disease ,Gastrointestinal Microbiome ,Black or African American ,030104 developmental biology ,Etiology ,030211 gastroenterology & hepatology ,business - Abstract
In their outstanding study, Wei et al 1 compared the intestinal microbiota (IM) of well-defined autoimmune hepatitis (AIH) patients to healthy controls. They reported significantly reduced IM alpha diversity and disparate IM compositional heterogeneity (beta diversity) with enrichment of Streptococcus , Veillonella , Klebsiella and Lactobacillus in AIH. The excellent achievement of this study is to have characterised the IM of untreated patients with AIH. However, differentiation between IM changes caused by AIH in particular and by chronic liver disease (CLD) in general was not possible because this study lacked a control group with CLD other than AIH. In a pilot study, we analysed the IM of patients with CLD of mixed aetiology in comparison to healthy controls to clarify alterations across different stages of CLD (table 1 and online supplementary data). In contrast to the study by Wei et al , patients with recent intake of antibiotics were excluded. Additionally, only patients on proton pump inhibitors (PPIs), which are frequently taken by patients with CLD, were included to avoid a bias due to mixed PPI use, because PPI can alter the IM, in particular, the abundance of Veillonellaceae and Streptococcaceae.2 Based on investigations of normalised relative reads (n-RR) per IM taxon as well as IM alpha-diversity and beta-diversity analyses, we detected Veillonella …
- Published
- 2020
10. Suppressive myeloid cells are a hallmark of severe COVID-19
- Author
-
Daniel Wendisch, Christof von Kalle, Theodore S. Kapellos, Henrik E. Mei, Kristian Händler, Katrin-Moira Heim, Kevin Baßler, Alexander Uhrig, Charlotte Thibeault, Miriam Stegemann, Christoph R. Glösenkamp, Antoine-Emmanuel Saliba, Lorenzo Bonaguro, Stephan Schlickeiser, Hans-Dieter Volk, Matthias Becker, Yang Li, Andreas C. Hocke, Elena De Domenico, Moritz Pfeiffer, Michael To Vinh, Michael Beckstette, Miriam Herbert, Sophia Brumhard, Martin Grasshoff, Kim Melanie Kaiser, Tobias Krammer, Arik Horne, Anna Drews, Norbert Suttorp, Birgit Sawitzki, Deutsche Covid Omics Initiative, Martin Witzenrath, Robert Geffers, Tal Pecht, Florian Kurth, Jacob Nattermann, Adem Saglam, Joachim L. Schultze, Jan Raabe, Bowen Zhang, Daniela Paclik, Linda Jürgens, Désirée Kunkel, Benjamin Krämer, Leif E. Sander, Jonas Schulte-Schrepping, Felix Machleidt, Cheng-Jian Xu, Christian Meisel, Claudia Conrad, Anna C. Aschenbrenner, Thomas Ulas, Stefan Hippenstiel, Oliver Dietrich, Gereon Rieke, Holger Müller-Redetzky, Axel Schulz, Christian Drosten, Nico Reusch, Christine Goffinet, Laure Bousquillon de Jarcy, and Ehsan Vafadarnejad
- Subjects
ARDS ,Myeloid ,business.industry ,CD11c ,Inflammation ,medicine.disease ,Peripheral blood mononuclear cell ,Pathogenesis ,Immune system ,medicine.anatomical_structure ,Immunology ,medicine ,Myelopoiesis ,medicine.symptom ,business - Abstract
‘Severe Acute Respiratory Syndrome - Coronavirus-2’ (SARS-CoV-2) infection causes Coronavirus Disease 2019 (COVID-19), a mild to moderate respiratory tract infection in the majority of patients. A subset of patients, however, progresses to severe disease and respiratory failure with acute respiratory distress syndrome (ARDS). Severe COVID-19 has been associated with increased neutrophil counts and dysregulated immune responses. The mechanisms of protective immunity in mild forms and the pathogenesis of dysregulated inflammation in severe courses of COVID-19 remain largely unclear. Here, we combined two single-cell RNA-sequencing technologies and single-cell proteomics in whole blood and peripheral blood mononuclear cells (PBMC) to determine changes in immune cell composition and activation in two independent dual-center patient cohorts (n=46+n=54 COVID-19 samples), each with mild and severe cases of COVID-19. We observed a specific increase of HLA-DRhiCD11chiinflammatory monocytes that displayed a strong interferon (IFN)-stimulated gene signature in patients with mild COVID-19, which was absent in severe disease. Instead, we found evidence of emergency myelopoiesis, marked by the occurrence of immunosuppressive pre-neutrophils and immature neutrophils and populations of dysfunctional and suppressive mature neutrophils, as well as suppressive HLA-DRtomonocytes in severe COVID-19. Our study provides detailed insights into systemic immune response to SARS-CoV-2 infection and it reveals profound alterations in the peripheral myeloid cell compartment associated with severe courses of COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
11. CD4 regulatory T cells in hepatocellular carcinoma with different etiologies
- Author
-
Benjamin Krämer, A Hausen, Jacob Nattermann, Ulrich Spengler, Leona Dold, Christian P. Strassburg, Philipp Lutz, Maria A. Gonzalez-Carmona, Hans-Dieter Nischalke, and Bettina Langhans
- Subjects
business.industry ,Hepatocellular carcinoma ,Gastroenterology ,Etiology ,Cancer research ,Medicine ,business ,medicine.disease - Published
- 2018
- Full Text
- View/download PDF
12. Looking left or looking right? Effects of newspaper layout style on the perception of political news
- Author
-
Benjamin Krämer, Philipp Müller, and Johanna Schindler
- Subjects
Multimedia ,business.industry ,Communication ,media_common.quotation_subject ,05 social sciences ,Media studies ,050801 communication & media studies ,Graphic design ,computer.software_genre ,Visual appearance ,Language and Linguistics ,0506 political science ,Newspaper ,Biology and political orientation ,Style (sociolinguistics) ,Politics ,0508 media and communications ,Perception ,050602 political science & public administration ,Quality (business) ,business ,Psychology ,computer ,media_common - Abstract
The perception of political messages may not only be shaped by textual information, but also by its visual appearance. An online experiment investigated how newspaper articles’ layout style and text slant affect the perception of a newspapers’ political orientation on the left-right axis. The layout versions were based on a prior analysis of correlations between design and political direction of quality newspapers. Results suggest the existence of political layout effects: a conservative layout style led to the source of a left-wing slanted text being estimated more right-wing, especially for left-wing-oriented participants. However, it had no effect when it was combined congruently with a right-wing slanted text. A progressive layout style had only an effect for participants with more knowledge on quality newspapers, leading them to locate the source more left-wing.
- Published
- 2017
- Full Text
- View/download PDF
13. Populist online practices: the function of the Internet in right-wing populism
- Author
-
Benjamin Krämer
- Subjects
business.industry ,Communication ,media_common.quotation_subject ,05 social sciences ,Media studies ,Identity (social science) ,050801 communication & media studies ,Political communication ,Library and Information Sciences ,Ingroups and outgroups ,0506 political science ,Representation (politics) ,Populism ,0508 media and communications ,Political science ,050602 political science & public administration ,The Internet ,Ideology ,Function (engineering) ,business ,media_common - Abstract
This article develops a theoretical classification of functions of different Internet applications and plattforms in right-wing populism. Its aim is to understand how the Internet is seen and used by populists and how it contributes to populism. Online communication by both populist leaders or organizations and non-organized actors is discussed. Main functions include the representation of the relationship between leaders and ‘the people,’ justifying the exclusion of outgroups, the conceptual elaboration of the right-wing populist ideology, developing a right-wing populist lifestyle and identity, and circumventing the traditional media.
- Published
- 2017
- Full Text
- View/download PDF
14. Pepe – Just a Funny Frog? A Visual Meme Caught Between Innocent Humor, Far-Right Ideology, and Fandom
- Author
-
Rebecca Venema, Katharina Lobinger, Benjamin Krämer, and Eleonora Benecchi
- Subjects
Far right ,Literature ,business.industry ,media_common.quotation_subject ,Ideology ,Art ,Fandom ,business ,media_common - Published
- 2020
- Full Text
- View/download PDF
15. Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection
- Author
-
Carolynne Schwarze-Zander, M To Vinh, Jacob Nattermann, Kim Melanie Kaiser, C Hoffmeister, C Finnemann, K Dobrikova, C Gotter, Jan Raabe, Christian P. Strassburg, Benjamin Krämer, Vanessa Schmitt, Christoph Wilhelm, Juergen K. Rockstroh, and Ulrich Spengler
- Subjects
Hiv hcv coinfection ,business.industry ,Medicine ,business ,Virology - Published
- 2019
- Full Text
- View/download PDF
16. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C
- Author
-
Christoph Boesecke, Jacob Nattermann, Christian P. Srassburg, Andreas Glässner, Ulrich Spengler, Benjamin Krämer, Jürgen K. Rockstroh, P Kokordelis, Esther Voigt, Patrick Ingiliz, and F Wolter
- Subjects
Adult ,Male ,CD3 Complex ,Hepacivirus ,HIV Infections ,Virus Replication ,Interferon-gamma ,Young Adult ,Immune system ,T-Lymphocyte Subsets ,Interferon ,medicine ,Humans ,Pharmacology (medical) ,Interferon gamma ,Cells, Cultured ,biology ,business.industry ,virus diseases ,Middle Aged ,Flow Cytometry ,Natural killer T cell ,medicine.disease ,biology.organism_classification ,Hepatitis C ,Virology ,CD56 Antigen ,Infectious Diseases ,Interleukin 15 ,Immunology ,Hepatocytes ,Interleukin 12 ,Coinfection ,Natural Killer T-Cells ,Female ,business ,medicine.drug - Abstract
OBJECTIVE To analyze the role of CD3(+)CD56(+) natural killer (NK)-like T cells in HIV(+) patients with acute hepatitis C. DESIGN Frequency, phenotype, and anti-hepatitis C virus (HCV) activity of CD3(+)CD56(+) NK-like T cells were studied in 36 HIV(+) patients with acute hepatitis C. As controls, 12 patients with chronic HCV/HIV coinfection, 8 HIV monoinfected patients, and 12 healthy donors were enrolled in this study. METHODS CD3(+)CD56(+) NK-like T-cell-mediated inhibition of HCV replication was analyzed using the HuH7A2HCVreplicon model. The CD3(+)CD56(+) NK-like T-cell phenotype and interferon (IFN)-γ secretion were studied by flow cytometry. RESULTS Interleukin 12/interleukin 15 stimulated CD3(+)CD56(+) NK-like T cells from healthy donors effectively block HCV replication in vitro in an IFN-γ dependent manner. Accordingly, we found that blocking of IFN-γ with a specific antibody significantly reduced the antiviral activity of CD3(+)CD56(+) NK-like T cells. However, when CD3(+)CD56(+) NK-like T cells from HIV(+) patients were studied, we found HIV infection to be associated with a significantly impaired IFN-γ production, irrespective of HCV coinfection. Accordingly, CD3(+)CD56(+) NK-like T cells from HIV(+) patients were significantly less effective in blocking HCV replication in vitro than cells from healthy individuals. CONCLUSIONS Taken together, our data indicate that HIV infection is associated with an impaired anti-HCV activity of CD3(+)CD56(+) NK-like T cells, which might represent a novel mechanism of dysregulated immune response in HIV/HCV-coinfected patients.
- Published
- 2015
- Full Text
- View/download PDF
17. Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: Results from a randomised controlled trial
- Author
-
Benjamin Krämer, S Wingart, Danijel Jelusic, D Stojanovic, S Fuchs, Konrad Schultz, Nicola Lehbert, V Huber, Michael Wittmann, Harma Alma, Corina de Jong, O Göhl, Michael Schuler, Hermann Faller, Thys van der Molen, and Groningen Research Institute for Asthma and COPD (GRIAC)
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,OBSTRUCTIVE PULMONARY-DISEASE ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,Quality of life ,law ,Severity of illness ,medicine ,Pulmonary rehabilitation ,030212 general & internal medicine ,DYSPNEA ,COPD ,Rehabilitation ,IMPORTANT DIFFERENCE ,business.industry ,Inspiratory muscle training ,ADULTS ,medicine.disease ,Obstructive lung disease ,030228 respiratory system ,Physical therapy ,business - Abstract
The value of inspiratory muscle training (IMT) in pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD) is unclear. The RIMTCORE (Routine Inspiratory Muscle Training within COPD Rehabilitation) randomised controlled trial examined the effectiveness of IMT added to pulmonary rehabilitation.In total, 611 COPD patients (Global Initiative for Chronic Obstructive Lung Disease stage II–IV) received a 3-week inpatient pulmonary rehabilitation, of which 602 patients were included in the intention-to-treat analyses. The intervention group (n=300) received highly intensive IMT and the control group (n=302) received sham IMT. The primary outcome was maximal inspiratory pressure (PImax). The secondary outcomes were 6-min walk distance, dyspnoea, quality of life and lung function. Outcomes were assessed pre- and post-pulmonary rehabilitation. ANCOVA was used.The intervention group showed higher effects in PImax (pIMT as an add-on to a 3-week pulmonary rehabilitation improves inspiratory muscle strength, but does not provide additional benefits in terms of exercise capacity, quality of life or dyspnoea. A general recommendation for COPD patients to add IMT to a 3-week pulmonary rehabilitation cannot be made.
- Published
- 2018
18. Social Ontologies Online: The Representation of Social Structures on the Internet
- Author
-
Benjamin Krämer and Julia Conrad
- Subjects
Cultural Studies ,050402 sociology ,Social computing ,Computer science ,business.industry ,Online participation ,Communication ,05 social sciences ,050801 communication & media studies ,ComputerApplications_COMPUTERSINOTHERSYSTEMS ,Social web ,Data structure ,lcsh:P87-96 ,Computer Science Applications ,lcsh:Communication. Mass media ,World Wide Web ,0508 media and communications ,0504 sociology ,Social media ,The Internet ,Sociology of the Internet ,business ,Social structure - Abstract
It is commonly said that “there are” social structures on the Internet. But how can they exist there, how can we identify and classify them? A theoretical and methodological framework is presented that describes the relationship between data structures, algorithms, and different types of social structures. We suggest that the latter are “represented” online in different senses of the word: They are not only described, but, by manipulating data, social structures can also be constituted and modified. We then outline a methodology for the analysis of social structures on the Internet: By analyzing the practical meaning of the structures of Internet platforms, we can reconstruct their providers’ and users’ ontological commitments (i.e., what kinds of social structures they have to assume “there are”).
- Published
- 2017
19. CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients
- Author
-
M Eisenhardt, Benjamin Krämer, Christoph Boesecke, Ulrich Spengler, Andreas Glässner, Jacob Nattermann, P Kokordelis, Jürgen K. Rockstroh, Hans-Dieter Nischalke, and F Wolter
- Subjects
Adult ,Male ,Hepacivirus ,Hepatitis C virus ,Immunology ,Human immunodeficiency virus (HIV) ,HIV Infections ,chemical and pharmacologic phenomena ,medicine.disease_cause ,Flow cytometry ,Interferon ,medicine ,Humans ,Immunology and Allergy ,Secretion ,Aged ,medicine.diagnostic_test ,biology ,business.industry ,virus diseases ,hemic and immune systems ,Hepatitis C ,Middle Aged ,Flow Cytometry ,medicine.disease ,biology.organism_classification ,Virology ,CD56 Antigen ,Lymphocyte Subsets ,digestive system diseases ,Tumor Necrosis Factor Receptor Superfamily, Member 7 ,Killer Cells, Natural ,Infectious Diseases ,Female ,Interferons ,Acute hepatitis C ,business ,medicine.drug - Abstract
Objective The objective of this study was to analyse the potential role of CD27 in natural killer (NK) cell-mediated control of hepatitis C virus (HCV) infection in HIV-positive patients. Design Frequency of CD27-expressing CD56 NK cells was analysed in HIV mono-infected individuals and HIV-positive patients with acute or chronic hepatitis C. Anti-HCV activity of CD27(+) and CD27(-) NK cells was compared. Methods NK cell mediated inhibition of HCV replication was analysed using the HUH7 HCV Replicon model. NK cell phenotype and interferon (IFN) secretion was studied by flowcytometry. Results High frequency of CD27(+)CD56 NK cells is associated with spontaneous clearance of acute hepatitis C in HIV-positive patients. Accordingly, we found CD27(+)CD56 NK cells to display strong anti-HCV activity. Conclusion Our results underline the important role of NK cells in modulating outcome of HCV infection.
- Published
- 2014
- Full Text
- View/download PDF
20. Media Populism: A Conceptual Clarification and Some Theses on its Effects
- Author
-
Benjamin Krämer
- Subjects
Radio communications ,Linguistics and Language ,business.industry ,Communication ,media_common.quotation_subject ,Media studies ,Popular culture ,Language and Linguistics ,Populism ,Politics ,Rhetoric ,The Internet ,Sociology ,Social science ,business ,media_common - Abstract
On the basis of a review of the literature on populism and a definition of populism in general, the concept of media populism is developed. The structural position of media organizations is analyzed regarding the opportunities and constraints when using a populist rhetoric and populist political claims. Two exemplary cases of media populism (typical elements can be found in the tabloid press and in talk radio), and its prevalence in popular culture and on the Internet are discussed. Theses on the effects of media populism are developed, based on cognitive schemata and the dynamics of climates of opinion (or perceived orthodoxies).
- Published
- 2014
- Full Text
- View/download PDF
21. Strategies of Media Use
- Author
-
Benjamin Krämer
- Subjects
Linguistics and Language ,Sociology and Political Science ,business.industry ,Communication ,Media use ,Internet privacy ,Sociology ,business ,Language and Linguistics ,lcsh:P87-96 ,lcsh:Communication. Mass media - Abstract
Mediennutzung wird hier theoretisch als strategische Praxis (im Sinne Bourdieus) gefasst, die zu langfristigen Profiten führt oder von kurzfristigen taktischen Orientierungen geleitet ist. Mittels Strategien der Mediennutzung passen sich Rezipienten der Struktur von Situationen, Medieninhalten und Technologien an; ferner sind Strategien mit der Sozialstruktur verknüpft. Die Reichweite einer Strategie (was die dabei aufgewendeten Einsätze und die Profite betrifft) kann weiter sein als ihr bewusster Anwendungsbereich, d. h. der Teil der subjektiven Realität, der im Prozess der Auswahl und Nutzung von Medien berücksichtigt wird. Auf verschiedenen Ebenen wie derjenigen der Modalität, des Fokus, der Haltung, des Stils, Repertoires und Arrangements können Handelnde Strategieelemente auswählen, um ihre Ziele zu erreichen und Gratifikationen zu erlangen. Die vorliegende praxeologische Analyse verbindet strukturelle und phänomenologische Perspektiven auf Mediennutzung.
- Published
- 2013
- Full Text
- View/download PDF
22. Alterations of the NK cell pool in HIV/HCV co-infection
- Author
-
Dominik J. Kaczmarek, Jacob Nattermann, Benjamin Krämer, Carolynne Schwarze-Zander, P Kokordelis, Ulrich Spengler, Andreas Glässner, F Wolter, Christoph Boesecke, Jürgen K. Rockstroh, Philipp Lutz, Felix Goeser, and Christian P. Strassburg
- Subjects
0301 basic medicine ,RNA viruses ,Male ,Cell ,lcsh:Medicine ,HIV Infections ,NK cells ,Hepacivirus ,medicine.disease_cause ,Pathology and Laboratory Medicine ,Cell Degranulation ,Geographical Locations ,Liver disease ,0302 clinical medicine ,Spectrum Analysis Techniques ,Immunodeficiency Viruses ,Germany ,Cellular types ,Interferon gamma ,lcsh:Science ,Multidisciplinary ,medicine.diagnostic_test ,Hepatitis C virus ,Coinfection ,Immune cells ,virus diseases ,Hepatitis C ,Middle Aged ,Flow Cytometry ,Europe ,Killer Cells, Natural ,medicine.anatomical_structure ,Infectious Diseases ,Medical Microbiology ,Spectrophotometry ,Viral Pathogens ,Viruses ,White blood cells ,030211 gastroenterology & hepatology ,Cytophotometry ,Pathogens ,medicine.drug ,Research Article ,Adult ,Cell biology ,Blood cells ,Cell Physiology ,Immunology ,Viral diseases ,Research and Analysis Methods ,Microbiology ,Flow cytometry ,03 medical and health sciences ,Interferon-gamma ,Young Adult ,Retroviruses ,medicine ,Humans ,Lymphocyte Count ,Microbial Pathogens ,Aged ,Medicine and health sciences ,Biology and life sciences ,Flaviviruses ,business.industry ,Lentivirus ,lcsh:R ,Case-control study ,Organisms ,HIV ,medicine.disease ,Virology ,Hepatitis viruses ,030104 developmental biology ,Cross-Sectional Studies ,Animal cells ,Co-Infections ,Case-Control Studies ,People and Places ,lcsh:Q ,business - Abstract
Background A relevant proportion of human immunodeficiency virus (HIV) infected patients is co-infected with the hepatitis C virus (HCV). HCV co-infection in HIV-positive patients is associated with faster progression of liver disease in comparison to HCV mono-infection. Natural killer (NK) cells critically modulate the natural course of HCV infection. Both HIV and HCV mono-infection are associated with alterations of the NK cell pool. However, little data is available concerning phenotype and function of NK cells in HIV/HCV co-infection. Methods A total of 34 HIV/HCV co-infected, 35 HIV and 39 HCV mono-infected patients and 43 healthy control persons were enrolled into this study. All HIV-positive patients were under effective antiretroviral therapy. NK cell phenotype, IFN-γ production and degranulation were studied by flow cytometry. Results NK cell frequency in HIV/HCV co-infection was significantly lower than in healthy individuals but did not differ from HIV and HCV mono-infection. HIV/HCV co-infection was associated with significantly decreased expression of the maturation/differentiation markers CD27/62L/127 on NK cells but increased expression of CD57 compared to healthy controls. Of note, expression also differed significantly from HCV mono-infection but was similar to HIV mono-infection, suggesting a pronounced impact of HIV on these alterations. Similar findings were made with regard to the NK cell receptors NKG2A/C and NKp30. More importantly, NK cells in co-infection displayed a highly impaired functional activity with significantly lower IFN-γ production and degranulation than in healthy donors as well as HIV and HCV mono-infection, suggesting a synergistic effect of both viruses. Conclusions Our data indicate that HIV/HCV co-infection is associated with significant alterations of the NK cell pool, which might be involved in the rapid progression of liver disease in co-infected patients and which mainly reflect alterations observed in HIV mono-infection.
- Published
- 2017
23. VOT4CS
- Author
-
Sebastian Banescu, Ciprian Lucaci, Benjamin Krämer, and Alexander Pretschner
- Subjects
0301 basic medicine ,Reverse engineering ,Java ,business.industry ,Computer science ,020207 software engineering ,02 engineering and technology ,man-at-the-end attacks, obfuscation, software protection ,Virtualization ,computer.software_genre ,Computer security ,ddc ,Obfuscation (software) ,03 medical and health sciences ,030104 developmental biology ,Software ,0202 electrical engineering, electronic engineering, information engineering ,x86 ,Managed code ,Software engineering ,business ,computer ,Machine code ,computer.programming_language - Abstract
Software protection is a difficult task especially for managed code, which executes only on a runtime environment such as C# or Java. Applications developed in such languages can be accurately decompiled, as opposed to x86 machine code. This facilitates reverse engineering attacks, with the goal of extracting proprietary algorithms. Due to the ease of distributing software copies across different jurisdictions, software developers cannot only rely on legal means for protection against reverse engineering attacks. Therefore, they have to employ technical means for software protection such as obfuscation. This paper presents an open source tool for virtualization obfuscation of programs written in the C# language, called VOT4CS. Our tool offers several possibilities for randomization that aim to confuse attacks based on pattern recognition. An evaluation of VOT4CS is performed based on several case-studies, which show the performance-security trade-off offered by the tool.
- Published
- 2016
- Full Text
- View/download PDF
24. Routine IMT within COPD Rehabilitation (RIMTCORE-RCT): Are there subgroups with clinical benefits?
- Author
-
V Huber, S Wingart, Michael Schuler, Benjamin Krämer, S Fuchs, Danijel Jelusic, Konrad Schultz, Michael Wittmann, and Nicola Lehbert
- Subjects
COPD ,medicine.medical_specialty ,Rehabilitation ,Copd patients ,business.industry ,medicine.medical_treatment ,medicine.disease ,humanities ,law.invention ,Randomized controlled trial ,law ,Secondary analysis ,Internal medicine ,medicine ,Physical therapy ,In patient ,business - Abstract
Background: RIMTCORE study showed (ERS Congress 2015) that IMT within a 3-week-PR leads to benefits concerning PI max and FIV1 but not with respect to QoL (SGRQ, CAT) and 6MWD. This secondary analysis aims to clarify if there are subgroups with clinical benefits. Methods: RCT, 602 COPD patients GOLD grade 2-4 (IG/GC n = 300/302), intention-to-treat-analysis. Results: Significant moderator effects for gender were found in CAT (p
- Published
- 2016
- Full Text
- View/download PDF
25. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis
- Author
-
Benjamin Krämer, Stefan Schlabe, Marijo Parcina, Dominik J. Kaczmarek, Christian P. Strassburg, Hans Dieter Nischalke, Jacob Nattermann, Felix Goeser, Philipp Lutz, Ulrich Spengler, and Achim Hoerauf
- Subjects
Liver Cirrhosis ,Male ,medicine.medical_specialty ,medicine.drug_class ,Clinical Biochemistry ,Antibiotics ,Drug resistance ,Peritonitis ,Biochemistry ,Meropenem ,Microbiology ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,Spontaneous bacterial peritonitis ,Ciprofloxacin ,Internal medicine ,Streptococcal Infections ,Drug Resistance, Bacterial ,medicine ,Humans ,Prospective Studies ,Escherichia coli Infections ,Gram-Positive Bacterial Infections ,Aged ,Cross Infection ,biology ,business.industry ,Ceftriaxone ,General Medicine ,Bacterial Infections ,biochemical phenomena, metabolism, and nutrition ,Middle Aged ,biology.organism_classification ,medicine.disease ,Anti-Bacterial Agents ,Klebsiella Infections ,Enterococcus ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Female ,Thienamycins ,business ,medicine.drug - Abstract
Background Spontaneous bacterial peritonitis (SBP) can be life-threatening in patients with liver cirrhosis. In contrast to community-acquired SBP, no standard treatment has been established for healthcare-related and nosocomial SBP. Patients and methods We prospectively collected healthcare-related and nosocomial SBP cases from March 2012 till February 2016 at the Department of Internal Medicine I of the University of Bonn and analysed the prevalence of antibiotic resistance among the isolated bacteria. SBP was diagnosed according to international guidelines. Ciprofloxacin, ceftriaxone and meropenem were used as reference substance for resistance to quinolones, third-generation cephalosporins and carbapenems, respectively. Results Ninety-two SBP episodes in 86 patients were identified: 63 episodes (69%) were nosocomial. Escherichia coli, Klebsiella species, enterococci and streptococci were most frequently isolated. Frequency of these microorganisms were comparable for healthcare-related and nosocomial SBP (14 vs. 11%, 14 vs. 8%, 14 vs. 5% and 10 vs. 6%, respectively). In general, antibiotic resistance was higher in isolates from nosocomial than from healthcare-related SBP (50% vs. 18% for quinolones, 30 vs. 11% for piperacillin-tazobactam; p>0.05), but comparable concerning third-generation cephalosporins (30 vs. 33%). All microorganisms were sensitive to carbapenems apart from nosocomial infections with Enterococcus faecium (n=3) and Candida albicans (n=1) due to intrinsic resistance or lack of microbiological efficacy, respectively. No multidrug-resistant microorganisms were detected. Resistance to initial antibiotic treatment affected 30-day survival negatively (18% vs. 68%; p=0.002). Conclusion Resistance to initial antibiotic treatment was associated with increased mortality. With resistance to cephalosporins being frequent, piperacillin-tazobactam or carbapenems might be preferred as treatment of SBP. This article is protected by copyright. All rights reserved.
- Published
- 2016
26. Hepatitis C Coinfection Enhances Sensitization of CD4+ T-Cells Towards Fas-Induced Apoptosis in Viraemic and Haart-Controlled HIV-1-Positive Patients
- Author
-
Felix Tolksdorf, D. Schulte, Katarina Riesner, Jacob Nattermann, Ulrich Spengler, Jürgen K. Rockstroh, Christian Körner, and Benjamin Krämer
- Subjects
Adult ,CD4-Positive T-Lymphocytes ,Male ,Fas Ligand Protein ,Human immunodeficiency virus (HIV) ,Apoptosis ,HIV Infections ,Hepacivirus ,medicine.disease_cause ,Antiretroviral Therapy, Highly Active ,medicine ,Humans ,Pharmacology (medical) ,In patient ,fas Receptor ,Potential mechanism ,Sensitization ,Aged ,Pharmacology ,Coinfection ,business.industry ,virus diseases ,Hepatitis C ,Middle Aged ,medicine.disease ,Virology ,Infectious Diseases ,medicine.anatomical_structure ,HIV-1 ,Female ,business - Abstract
Background Recently, we identified increased rates of CD4+ T-cell apoptosis in HCV-infected HIV-positive patients as a potential mechanism for enhanced mortality in patients with HIV/HCV coinfection. Since this effect might be attributed to changes in receptor-induced apoptosis, we studied expression and function of Fas ligand (FasL) and its death receptor Fas on CD4+ T-cells in HIV/HCV coinfection. Methods In this cross-sectional study, we simultaneously analysed surface expression of Fas and FasL on CD4+ T-cells and serum levels of soluble FasL in HCV/HIV-coinfected, HIV-monoinfected and HCV-monoinfected patients. Susceptibility to FasL-induced apoptosis was analysed by incubating isolated peripheral blood mono-nuclear cells with rhFasL followed by measuring CD4+ T-cell apoptosis. Results HIV and HCV monoinfection were associated with significantly enhanced surface expression of Fas. Highest Fas expression was detected in HIV/HCV-coinfected patients and correlated with low CD4+ T-cell counts. By contrast, elevated levels of soluble and cellular FasL were found only in patients with HIV infection, but not in patients with HCV infection. Importantly, enhanced Fas expression in HCV/HIV coinfection rendered CD4+ T-cells more susceptible towards FasL-induced apoptosis. While effective HAART normalized expression and secretion of FasL in HIV-infected and HIV/HCV-coinfected patients, expression of Fas decreased only slightly and still remained significantly elevated as compared with healthy controls. Conclusions Our findings suggest a synergistic mechanism in HIV/HCV coinfection between up-regulation of Fas expression on CD4+ T-cells and HIV-induced elevated levels of cellular and soluble FasL. Together, both effects contribute to enhanced apoptosis of CD4+ T-cells in HIV/HCV coinfection.
- Published
- 2011
- Full Text
- View/download PDF
27. Ascites NK cells are phenotypically distinct from blood and liver NK cells in patients with liver cirrhosis and become activated by bacterial stimulation in-vitro and during spontaneous bacterial peritonitis
- Author
-
Jacob Nattermann, Benjamin Krämer, Y.H. Oo, Hannah C. Jeffery, N. Jones, Philipp Lutz, J. Birtwistle, David H. Adams, Ulrich Spengler, and Christian P. Strassburg
- Subjects
Cirrhosis ,Spontaneous bacterial peritonitis ,Hepatology ,business.industry ,Ascites ,Bacterial stimulation ,Medicine ,In patient ,medicine.symptom ,business ,medicine.disease ,In vitro ,Microbiology - Published
- 2018
- Full Text
- View/download PDF
28. Ascites total protein may be modulated by the use of diuretics
- Author
-
Benjamin Krämer, Hans-Dieter Nischalke, Jacob Nattermann, Ulrich Spengler, DJ Kaczmarek, F Goeser, Christian P. Strassburg, Bettina Langhans, and Philipp Lutz
- Subjects
medicine.medical_specialty ,Endocrinology ,business.industry ,Internal medicine ,Ascites ,Gastroenterology ,medicine ,medicine.symptom ,business ,Total protein - Published
- 2015
- Full Text
- View/download PDF
29. Effects of routine inspiratory muscle training (IMT) as add-on to pulmonary rehabilitation (PR) in COPD
- Author
-
S Fuchs, Danijel Jelusic, V Huber, Konrad Schultz, Michael Schuler, S Wingart, Benjamin Krämer, Michael Wittmann, Dragan Stojanovic, and Nicola Lehbert
- Subjects
medicine.medical_specialty ,COPD ,business.industry ,medicine.medical_treatment ,Inspiratory muscle training ,Exercise capacity ,medicine.disease ,law.invention ,Primary outcome ,Randomized controlled trial ,Quality of life ,law ,Baseline characteristics ,Internal medicine ,Physical therapy ,Cardiology ,Medicine ,Pulmonary rehabilitation ,business - Abstract
Background: Up to now it is unclear whether IMT as a routine add-on to PR improves clinical outcome in COPD patients. Method: We underwent a RCT with 555 COPD-patients GOLD-stage 2-4. OFEV1 = 1.42 l = 46.4% pred., O age 57,6 years, 65.1% male. The intervention group (IG; n= 278) provided 7 days/week 21 min. high intensive IMT as routine add-on to a comprehensive 3-week inpatient PR-program. The control group (CG, n = 277) underwent the same intensive PR-program (standard PR) but with a sham IMT of identical duration. There was no difference in the baseline characteristics between the two groups. Primary outcome: maximal inspiratory mouth pressure (PI,max). Secondary outcomes: Vital capacity (VC), forced expiratory and inspiratory volume in 1 second (FEV1, FIV1), 6MWD, Quality of life (SGRQ) and dyspnea (TDI). Results: First analysis of the subgroup of patients with PI, max ≤ 6 kPa didn´t show other significant differences. Discussion: Routine IMT as add-on to PR resulted in a significant increase of PI max and FIV1. But there were no additional benefits in other outcomes like QoL, exercise capacity and dyspnea in comparison to the very good short-term effects of the standard PR. Further analysis of our data will focus on subgroups and the long-term effects of the still ongoing 1 year follow-up.
- Published
- 2015
- Full Text
- View/download PDF
30. A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis
- Author
-
Beate Appenrodt, Bettina Langhans, Benjamin Krämer, Jacob Nattermann, Dominik J. Kaczmarek, Ulrich Spengler, Achim Hoerauf, Frank Lammert, Christian P. Strassburg, Marc P. Hübner, Philipp Lutz, and Hans Dieter Nischalke
- Subjects
0301 basic medicine ,Adult ,Male ,Alcoholic liver disease ,medicine.medical_specialty ,Cirrhosis ,Genotype ,Nod2 Signaling Adaptor Protein ,Peritonitis ,Receptors, Cytoplasmic and Nuclear ,Gastroenterology ,Polymorphism, Single Nucleotide ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Spontaneous bacterial peritonitis ,Liver Cirrhosis, Alcoholic ,Risk Factors ,Internal medicine ,Ascites ,medicine ,Humans ,Chemokine CCL2 ,Aged ,Aged, 80 and over ,Hepatology ,business.industry ,Case-control study ,Nuclear Proteins ,Odds ratio ,Bacterial Infections ,Middle Aged ,medicine.disease ,Toll-Like Receptor 2 ,030104 developmental biology ,Case-Control Studies ,Immunology ,030211 gastroenterology & hepatology ,Female ,medicine.symptom ,business - Abstract
Background Spontaneous bacterial peritonitis is frequently a fatal infection in patients with liver cirrhosis. We investigated if nuclear dot protein 52 kDa ( NDP52 ), a negative regulator of toll-like receptor (TLR) signalling and autophagy adaptor protein, might be involved. Methods Two cohorts comprising 152 (derivation cohort) and 198 patients (validation cohort) with decompensated liver cirrhosis and 168 healthy controls were genotyped for the rs2303015 polymorphism in the NDP52 gene and prospectively followed-up for spontaneous bacterial peritonitis. Results Overall, 57 (38%) patients in the derivation cohort and 77 (39%) in the validation cohort had spontaneous bacterial peritonitis. Cirrhosis was due to alcohol abuse in 57% of the derivation and 66% of the validation cohort. In patients with alcoholic cirrhosis, patients with spontaneous bacterial peritonitis had an increased frequency of the NDP52 rs2303015 minor variant in the derivation ( p = 0.04) and in the validation cohort ( p = 0.01). Multivariate analysis confirmed this minor variant (odds ratio 4.7, p = 0.002) and the TLR2 −16934 TT variant (odds ratio 2.5, p = 0.008) as risk factors for spontaneous bacterial peritonitis. In addition, presence of the NDP52 minor variant affected survival negatively. Conclusion Presence of the NDP52 rs2303015 minor variant increases the risk for spontaneous bacterial peritonitis in patients with alcoholic cirrhosis.
- Published
- 2015
31. Use of beta-blockers is associated with improved 30 day survival in patients with spontaneous bacterial peritonitis
- Author
-
Benjamin Krämer, Jacob Nattermann, Christian P. Strassburg, Achim Hoerauf, Ulrich Spengler, S Schlabe, Bettina Langhans, Hans-Dieter Nischalke, and Philipp Lutz
- Subjects
medicine.medical_specialty ,Spontaneous bacterial peritonitis ,business.industry ,Internal medicine ,Gastroenterology ,Medicine ,In patient ,business ,medicine.disease ,Beta (finance) - Published
- 2015
- Full Text
- View/download PDF
32. The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
- Author
-
Hans Dieter Nischalke, Jacob Nattermann, P Kokordelis, Kenneth Pfarr, Tilman Sauerbruch, Christian P. Strassburg, Benjamin Krämer, Ulrich Spengler, Philipp Lutz, Andreas Glässner, Achim Hoerauf, F Wolter, and Felix Goeser
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Cirrhosis ,Clinical Biochemistry ,Peritonitis ,Enzyme-Linked Immunosorbent Assay ,Peritoneal Effusion ,Gastroenterology ,Spontaneous bacterial peritonitis ,Internal medicine ,Ascites ,medicine ,Ascitic Fluid ,Humans ,Stage (cooking) ,Aged ,biology ,business.industry ,Biochemistry (medical) ,C-reactive protein ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,C-Reactive Protein ,biology.protein ,Female ,Calprotectin ,medicine.symptom ,business ,Leukocyte L1 Antigen Complex ,Biomarkers - Abstract
Diagnosis of spontaneous bacterial peritonitis (SBP) is based on a differential ascites leukocyte count which does not provide prognostic information. We performed a pilot study to assess calprotectin in ascites as an alternative diagnostic and prognostic marker.We collected ascites from patients with liver cirrhosis from March 2012 to July 2013. Routine clinical and laboratory data of the patients were recorded. Ascites calprotectin levels were determined by ELISA.Overall, we collected 120 ascites samples from 100 patients with liver cirrhosis and from eight patients with malignant peritoneal effusion as disease control. Samples without infection had significantly lower calprotectin levels (median 34 ng/mL, range 5–795) than SBP samples (median 928 ng/mL, range 21–110,480; pThe ratio of ascites calprotectin to total protein may be a promising new diagnostic and prognostic marker in patients with liver cirrhosis and SBP and should be evaluated further.
- Published
- 2015
- Full Text
- View/download PDF
33. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease
- Author
-
Thomas Berg, Jonas Rosendahl, Jacob Nattermann, Janett Fischer, Benjamin Krämer, Felix Stickel, Michael Soyka, Tobias Müller, Nasser Semmo, Tilman Sauerbruch, Ulrich Spengler, Hans-Dieter Nischalke, Philipp Lutz, and Christian P. Strassburg
- Subjects
Alcoholic liver disease ,medicine.medical_specialty ,business.industry ,Internal medicine ,Hepatocellular carcinoma ,Gastroenterology ,medicine ,medicine.disease ,business ,Gene - Published
- 2014
- Full Text
- View/download PDF
34. P0484 : CD3(+)CD56(+) NK-like T cells show reduced anti-viral activity in acutely HCV/HIV infected patients
- Author
-
Christoph Boesecke, Juergen K. Rockstroh, Ulrich Spengler, Christian P. Strassburg, Andreas Glässner, P. Ingiliz, F Wolter, Esther Voigt, P Kokordelis, Benjamin Krämer, and Jacob Nattermann
- Subjects
Hepatology ,biology ,business.industry ,CD3 ,Viral Activity ,biology.protein ,Hiv infected patients ,Medicine ,business ,Virology - Published
- 2015
- Full Text
- View/download PDF
35. Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C
- Author
-
Axel Baumgarten, Esther Voigt, Hans-Jürgen Stellbrink, Christoph Boesecke, Jacob Nattermann, Juergen K. Rockstroh, Patrick Ingiliz, Benjamin Krämer, Stefan Mauss, Hans Dieter Nischalke, and Ulrich Spengler
- Subjects
Male ,Genotype ,Hepatitis C virus ,Immunology ,HIV Infections ,medicine.disease_cause ,Antiviral Agents ,chemistry.chemical_compound ,Acquired immunodeficiency syndrome (AIDS) ,Interferon ,Ribavirin ,medicine ,Immunology and Allergy ,Humans ,Sida ,Polymorphism, Genetic ,biology ,business.industry ,Interleukins ,virus diseases ,Hepatitis C ,Middle Aged ,medicine.disease ,biology.organism_classification ,Virology ,digestive system diseases ,Infectious Diseases ,Treatment Outcome ,chemistry ,Coinfection ,Female ,Viral disease ,Interferons ,business ,medicine.drug - Abstract
The IFNL4 ss469415590 polymorphism has recently be shown to better predict treatment response in chronic hepatitis than the IL28B rs12979860 variant. However, no data exist in patients with HIV/hepatitis C virus (HCV) coinfection. Analysing 206 HCV(+)/HIV(+) and 162 HCV(+)/HIV(-) patients, we found that compared with IL28B rs12979860, IFNL4 ss469415590 was strongly associated with response to interferon/ribavirin therapy in HCV(+)/HIV(-) individuals but not in HIV(+)/HCV(+) patients. Thus, effects of the IFNL4 variant may differ in HIV(+) and HIV(-) patients.
- Published
- 2013
36. TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
- Author
-
Tobias Müller, Andreas Glässner, Hans Dieter Nischalke, Christian Körner, M Eisenhardt, Benjamin Krämer, Thomas Berg, Ulrich Spengler, F Wolter, Tilman Sauerbruch, Jacob Nattermann, and Katarina Riesner
- Subjects
Male ,Cancer Research ,Apoptosis ,medicine.disease_cause ,Gastroenterology ,Gene Frequency ,Genotype ,Medicine ,HCC ,A683C (rs20576) ,Cancer ,Aged, 80 and over ,Liver Neoplasms ,Hepatitis C ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Phenotype ,Oncology ,Hepatocellular carcinoma ,HCV ,Female ,Liver cancer ,Viral load ,Research Article ,Adult ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Hepatitis C virus ,lcsh:RC254-282 ,Internal medicine ,Genetics ,Humans ,Genetic Predisposition to Disease ,DR4 ,Polymorphism ,Allele frequency ,Alleles ,Aged ,Proportional Hazards Models ,C626G (rs20575) ,Polymorphism, Genetic ,business.industry ,TRAIL receptor I ,Odds ratio ,medicine.disease ,digestive system diseases ,Receptors, TNF-Related Apoptosis-Inducing Ligand ,Immunology ,business - Abstract
Background Tumour surveillance via induction of TRAIL-mediated apoptosis is a key mechanism, how the immune system prevents malignancy. To determine if gene variants in the TRAIL receptor I (DR4) gene affect the risk of hepatitis C virus (HCV)-induced liver cancer (HCC), we analysed DR4 mutations C626G (rs20575) and A683C (rs20576) in HCV-infected patients with and without HCC. Methods Frequencies of DR4 gene polymorphisms were determined by LightSNiP assays in 159 and 234 HCV-infected patients with HCC and without HCC, respectively. 359 healthy controls served as reference population. Results Distribution of C626G and A683C genotypes were not significantly different between healthy controls and HCV-positive patients without HCC. DR4 variants 626C and 683A occurred at increased frequencies in patients with HCC. The risk of HCC was linked to carriage of the 626C allele and the homozygous 683AA genotype, and the simultaneous presence of the two risk variants was confirmed as independent HCC risk factor by Cox regression analysis (Odds ratio 1.975, 95% CI 1.205-3.236; p = 0.007). Furthermore HCV viral loads were significantly increased in patients who simultaneously carried both genetic risk factors (2.69 ± 0.36 × 106 IU/ml vs. 1.81 ± 0.23 × 106 IU/ml, p = 0.049). Conclusions The increased prevalence of patients with a 626C allele and the homozygous 683AA genotype in HCV-infected patients with HCC suggests that these genetic variants are a risk factor for HCC in chronic hepatitis C.
- Published
- 2012
37. Der CYP27B1–1260 Promoter Polymorphismus rs120877012 ist bei HCV/HIV koinfizierten Patienten signifikant mit einem Ansprechen auf die Therapie der Hepatitis C Erkrankung (SVR) assoziiert
- Author
-
Axel Baumgarten, Jacob Nattermann, Ulrich Spengler, P Kokordelis, Tilman Sauerbruch, Juergen K. Rockstroh, U Naumann, B Sibbing, Andreas Glässner, J Söhne, Patrick Ingiliz, Christoph Boesecke, M Eisenhardt, Benjamin Krämer, and Stefan Mauss
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Gastroenterology ,medicine ,Vitamin D and neurology ,Human immunodeficiency virus (HIV) ,medicine.disease_cause ,business - Published
- 2012
- Full Text
- View/download PDF
38. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
- Author
-
C. Amos, Cheryl Lassen, Benjamin Krämer, L.J. Dunn, Michelle Henley, Roland Buhl, and C. Disdier
- Subjects
Pulmonary and Respiratory Medicine ,Spirometry ,Male ,medicine.drug_class ,Scopolamine Derivatives ,Quinolones ,Severity of Illness Index ,Cholinergic Antagonists ,Drug Administration Schedule ,Medical Records ,law.invention ,Pulmonary Disease, Chronic Obstructive ,Randomized controlled trial ,Double-Blind Method ,law ,Adrenergic beta-2 Receptor Antagonists ,Forced Expiratory Volume ,medicine ,Anticholinergic ,Humans ,Tiotropium Bromide ,Adverse effect ,Aged ,COPD ,medicine.diagnostic_test ,business.industry ,Tiotropium bromide ,Middle Aged ,medicine.disease ,respiratory tract diseases ,Bronchodilator Agents ,Treatment Outcome ,Tolerability ,Anesthesia ,Indans ,Indacaterol ,Female ,business ,medicine.drug - Abstract
Two, once daily (q.d.) inhaled bronchodilators are available for the treatment of chronic obstructive pulmonary disease (COPD): the β(2)-agonist indacaterol and the anticholinergic tiotropium. This blinded study compared the efficacy of these two agents and assessed their safety and tolerability. Patients with moderate-to-severe COPD were randomised to treatment with indacaterol 150 μg q.d. (n=797) or tiotropium 18 μg q.d. (n=801) for 12 weeks. After 12 weeks, the two treatments had similar overall effects on "trough" (24 h post-dose) forced expiratory volume in 1 s. Indacaterol-treated patients had greater improvements in transition dyspnoea index (TDI) total score (least squares means 2.01 versus 1.43; p
- Published
- 2011
39. Efficacy And Safety Of Indacaterol 150 And 300g In Asian COPD Patients: A 12-Week, Placebo Controlled Study
- Author
-
Hisamichi Aizawa, Yoshinosuke Fukuchi, Sang-Haak Lee, Liang Wen Hang, Motoi Hosoe, Niyati Prasad, Masakazu Ichinose, Benjamin Krämer, Yuko Maruyama, Masaharu Kinoshita, and Naoko Okino
- Subjects
medicine.medical_specialty ,Copd patients ,business.industry ,Internal medicine ,medicine ,Placebo-controlled study ,Indacaterol ,business ,medicine.drug - Published
- 2011
- Full Text
- View/download PDF
40. Efficacy And Safety Of Indacaterol 75 G Once Daily In Patients With Moderate-To-Severe COPD
- Author
-
Clare Peckitt, James Meli, Sarah Filcek, Benjamin Krämer, Cheryl Lassen, and Edward Kerwin
- Subjects
Moderate to severe ,medicine.medical_specialty ,COPD ,business.industry ,Internal medicine ,medicine ,Indacaterol ,In patient ,Once daily ,business ,medicine.disease ,medicine.drug - Published
- 2011
- Full Text
- View/download PDF
41. Combining Once-Daily Bronchodilators In COPD: Indacaterol Plus Tiotropium Versus Tiotropium Alone
- Author
-
Benjamin Krämer, Donald A. Mahler, Sarah Filcek, Anthony D'Urzo, Cheryl Lassen, and Clare Peckitt
- Subjects
COPD ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Indacaterol ,Once daily ,medicine.disease ,business ,medicine.drug - Published
- 2011
- Full Text
- View/download PDF
42. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis
- Author
-
Ulrich Spengler, Thomas Berg, Benjamin Krämer, Frank Lammert, Jacob Nattermann, Tobias Müller, Hans Dieter Nischalke, Christian Körner, Cordula Berger, Carolin Luda, Frank Grünhage, Tilman Sauerbruch, Natascha Vidovic, Johannes Oldenburg, and Martin Coenen
- Subjects
Lifestyle Causes of Cancer ,Liver Cirrhosis ,Male ,Alcoholic liver disease ,Cirrhosis ,Gastroenterology and hepatology ,Gastroenterology ,Hepatitis ,Liver Cirrhosis, Alcoholic ,Risk Factors ,Aged, 80 and over ,education.field_of_study ,Multidisciplinary ,Cancer Risk Factors ,Liver Neoplasms ,Hepatitis C ,Middle Aged ,Infectious hepatitis ,Oncology ,Nutritional Correlates of Cancer ,Hepatocellular carcinoma ,Infectious diseases ,Medicine ,Female ,Liver cancer ,Research Article ,Adult ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Genotype ,Science ,Genetic Causes of Cancer ,Population ,Viral and Bacterial Causes of Cancer ,Viral diseases ,White People ,Young Adult ,Internal medicine ,Gastrointestinal Tumors ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,education ,Biology ,Liver diseases ,Aged ,Evolutionary Biology ,Population Biology ,business.industry ,Computational Biology ,Cancers and Neoplasms ,Membrane Proteins ,Hepatocellular Carcinoma ,Lipase ,medicine.disease ,digestive system diseases ,Case-Control Studies ,Genetic Polymorphism ,Steatohepatitis ,business ,Population Genetics - Abstract
BackgroundAn isoleucine>methionine mutation at position 148 in the PNPLA3 gene (p.I148M, rs738409) has recently been identified as a susceptibility factor for liver damage in steatohepatitis. Here, we studied whether the PNPLA3 rs738409 polymorphism also affects predisposition to hepatocellular carcinoma (HCC).MethodsWe compared distributions of PNPLA3 genotypes in 80 and 81 Caucasian patients with alcoholic and hepatitis C virus (HCV)-associated HCC to 80 and 81 age- and sex-matched patients with alcohol-related and HCV-related cirrhosis without HCC, respectively. PNPLA3 genotypes in 190 healthy individuals from the same population served as reference. Potential confounders obesity, diabetes, HCV genotype and HBV co-infection were controlled by univariate and multivariate logistic regression with forward variable selection.ResultsPNPLA3 genotypes were in Hardy-Weinberg equilibrium for all study groups. The frequency of the 148M allele was significantly (pConclusionThe PNPLA3 148M variant is a prominent risk factor for HCC in patients with alcoholic cirrhosis, while its effects are negligible in patients with cirrhosis due to HCV. This polymorphism provides an useful tool to identify individuals with particularly high HCC risk in patients with alcoholic liver disease that should be taken into account in future HCC prevention studies.
- Published
- 2011
43. Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone
- Author
-
Beatrix Balint, Benjamin Krämer, Carolynn Amos, Roger Owen, Henrik Watz, and Mark Higgins
- Subjects
Adult ,Male ,onset of action ,International Journal of Chronic Obstructive Pulmonary Disease ,Quinolones ,Placebo ,chronic obstructive pulmonary disease ,Pulmonary Disease, Chronic Obstructive ,indacaterol ,medicine ,Humans ,In patient ,Albuterol ,Salmeterol Xinafoate ,Aged ,Original Research ,COPD ,Cross-Over Studies ,business.industry ,General Medicine ,respiratory system ,Middle Aged ,medicine.disease ,Crossover study ,Confidence interval ,respiratory tract diseases ,Bronchodilator Agents ,Androstadienes ,Anesthesia ,Indans ,Salbutamol ,Indacaterol ,Fluticasone ,Female ,Onset of action ,business ,medicine.drug - Abstract
Beatrix Balint1, Henrik Watz2, Carolynn Amos3, Roger Owen3, Mark Higgins3, Benjamin Kramer4, On behalf of the INSURE* Study Investigators1Csongrád Megyei Önkormányzat Mellkasi Betegségek Szakkórháza, Deszk, Hungary; 2Pulmonary Research Institute, Hospital Grosshansdorf, Grosshansdorf, Germany; 3Novartis Horsham Research Centre, Horsham, West Sussex, UK; 4Novartis Pharmaceuticals, East Hanover, NJ, USA; *Indacaterol: starting quickly and remaining effective in COPDBackground: Indacaterol is a novel, inhaled once-daily ultra-long-acting ß2-agonist for the treatment of chronic obstructive pulmonary disease (COPD).Objectives: This study compared the onset of action of single doses of indacaterol 150 and 300 µg with salbutamol 200 µg, salmeterol-fluticasone 50/500 µg, and placebo in moderate-to-severe COPD patients.Methods: This was a multicenter, randomized, double-blind, placebo-controlled crossover study. The primary variable was forced expiratory volume in one second (FEV1) at five minutes postdose.Results: Out of 89 patients randomized (mean age 62 years), 86 completed the study. At five minutes postdose, both indacaterol doses were statistically and clinically superior to placebo (P< 0.001), with treatment–placebo differences in FEV1 of 100 (95% confidence interval [CI] 70–130) mL and 120 (95% CI 90–150) mL for indacaterol 150 and 300 µg, respectively. FEV1 at five minutes postdose with both indacaterol doses was numerically higher than for salbutamol (10 and 30 mL for indacaterol 150 and 300 µg, respectively) and significantly higher than for salmeterol-fluticasone (50 mL, P = 0.003; 70 mL, P< 0.001, respectively). Moreover, both indacaterol doses showed significantly higher FEV1 than placebo (P< 0.001) at all postdose time points. The numbers of patients with an FEV1 increase of at least 12% and 200 mL at five minutes postdose were 16 (18.8%), 24 (27.6%), 20 (23.3%), 8 (9.1%), and 3 (3.4%) for indacaterol 150 and 300 µg, salbutamol 200 µg, salmeterol-fluticasone 50/500 µg, and placebo, respectively.Conclusions: Single doses of indacaterol 150 and 300 µg demonstrated a fast onset of action similar to that for salbutamol and faster than that for salmeterol-fluticasone.Keywords: indacaterol, onset of action, chronic obstructive pulmonary disease
- Published
- 2010
44. Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
- Author
-
Cheryl Lassen, Benjamin Krämer, Stefano Centanni, Roger Owen, Oliver Kornmann, Ronald Dahl, and Angeli Dogra
- Subjects
Pulmonary and Respiratory Medicine ,Questionnaires ,Male ,medicine.medical_specialty ,medicine.drug_class ,Health Status ,Quinolones ,Placebo ,Drug Administration Schedule ,Pulmonary Disease, Chronic Obstructive ,Adrenal Cortex Hormones ,Bronchodilator ,Surveys and Questionnaires ,Medicine ,Humans ,Albuterol ,Salmeterol Xinafoate ,Aged ,COPD ,business.industry ,Respiratory disease ,Smoking ,Middle Aged ,medicine.disease ,respiratory tract diseases ,Bronchodilator Agents ,Respiratory Function Tests ,Clinical trial ,Dyspnea ,Anesthesia ,Indans ,Physical therapy ,Indacaterol ,Female ,Salmeterol ,business ,medicine.drug - Abstract
Indacaterol is a novel, inhaled, once-daily, ultra-long-acting β(2)-agonist bronchodilator recently approved in Europe for the treatment of chronic obstructive pulmonary disease (COPD). The aim of the present study was to investigate the efficacy and safety of indacaterol compared with placebo and the twice-daily β(2)-agonist, salmeterol, as an active control. Patients with moderate-to-severe COPD were randomised to 6 months double-blind treatment with indacaterol (150 μg once daily), salmeterol (50 μg twice daily) or placebo. The primary efficacy end-point was trough (24 h post-dose) forced expiratory volume in 1 s (FEV(1)) after 12 weeks. 1,002 patients were randomised and 838 (84%) completed the study. Indacaterol increased trough FEV(1) at week 12 by 170 mL over placebo (p
- Published
- 2010
- Full Text
- View/download PDF
45. Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD
- Author
-
Patricia Bleasdale, D Jack, Benjamin Krämer, Roland Buhl, Roger Owen, Ronald Dahl, Safety Study Investigators, Vladimir Nonikov, Helgo Magnussen, Kian Fan Chung, and Mark Higgins
- Subjects
Pulmonary and Respiratory Medicine ,BODE index ,Male ,medicine.drug_class ,Quinolones ,Placebo ,Drug Administration Schedule ,Pulmonary Disease, Chronic Obstructive ,Double-Blind Method ,Bronchodilator ,Forced Expiratory Volume ,Formoterol Fumarate ,medicine ,Humans ,Aged ,COPD ,Dose-Response Relationship, Drug ,business.industry ,Adrenergic beta-Agonists ,Middle Aged ,medicine.disease ,respiratory tract diseases ,Bronchodilator Agents ,Treatment Outcome ,Tolerability ,Ethanolamines ,Anesthesia ,Indans ,Salbutamol ,Indacaterol ,Female ,Formoterol ,business ,medicine.drug - Abstract
Udgivelsesdato: 2010-Jun BACKGROUND: Indacaterol is a long-acting inhaled beta(2)-agonist (LABA) for the treatment of chronic obstructive pulmonary disease (COPD). In previous studies, indacaterol provided 24 h bronchodilation on once-daily dosing with a fast onset of action. This study compared the efficacy and safety of indacaterol with the twice-daily LABA formoterol and placebo over 1 year. METHODS: Patients with moderate to severe COPD were randomised to receive once-daily indacaterol 300 microg (n=437) or 600 microg (n=428), twice-daily formoterol 12 microg (n=435) or placebo (n=432) for 52 weeks in a double-blind double-dummy parallel group study. The primary efficacy variable was forced expiratory volume in 1 s (FEV(1)) measured 24 h postdose after 12 weeks (indacaterol vs placebo). Other outcomes included dyspnoea (transition dyspnoea index, TDI), use of as-needed salbutamol, symptom-based measures recorded on diary cards, exacerbations, health status (St George's Respiratory Questionnaire), BODE index (body mass index, obstruction, dyspnoea, exercise), safety and tolerability. RESULTS: Indacaterol increased 24 h postdose FEV(1) after 12 weeks by 170 ml (both doses) versus placebo and by 100 ml versus formoterol (all p
- Published
- 2010
- Full Text
- View/download PDF
46. Indacaterol Provides Effective Bronchodilation In Patients With Chronic Obstructive Pulmonary Disease Irrespective Of Patient Age (<65 Or e65 Years)
- Author
-
Cheryl Lassen, Roland Buhl, Benjamin Krämer, Roger Owen, and Donald A. Mahler
- Subjects
medicine.medical_specialty ,Patient age ,business.industry ,Internal medicine ,Bronchodilation ,medicine ,Cardiology ,Indacaterol ,Pulmonary disease ,In patient ,business ,medicine.drug - Published
- 2010
- Full Text
- View/download PDF
47. The Effect Of Once-Daily Indacaterol On Health-Related Quality Of Life, Rescue Medication Use, And Exacerbation Rates In Patients With Moderate-to-Severe COPD: A Pooled Analysis Of Three Months Of Treatment
- Author
-
Roger Owen, Thomas Siler, Cheryl Lassen, Benjamin Krämer, Umit Yegen, and James Williams
- Subjects
Moderate to severe ,Health related quality of life ,COPD ,medicine.medical_specialty ,Exacerbation ,business.industry ,Rescue medication ,medicine.disease ,Pooled analysis ,Emergency medicine ,medicine ,Physical therapy ,Indacaterol ,In patient ,business ,medicine.drug - Published
- 2010
- Full Text
- View/download PDF
48. Indacaterol Provides Significant Bronchodilation In Patients With Chronic Obstructive Pulmonary Disease Irrespective Of Concomitant Inhaled Corticosteroid Use
- Author
-
Cheryl Lassen, Marc Decramer, James F. Donohue, Benjamin Krämer, and Roger Owen
- Subjects
medicine.medical_specialty ,business.industry ,Concomitant ,Internal medicine ,Bronchodilation ,medicine ,Cardiology ,Pulmonary disease ,Indacaterol ,In patient ,Corticosteroid use ,business ,medicine.drug - Published
- 2010
- Full Text
- View/download PDF
49. Once-daily Indacaterol Provides Significant Bronchodilation In Chronic Obstructive Pulmonary Disease Patients Irrespective Of Baseline Reversibility
- Author
-
Eric C. Kleerup, Benjamin Krämer, Anthony D'Urzo, Roger Owen, and Cheryl Lassen
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Bronchodilation ,Cardiology ,Pulmonary disease ,Medicine ,Indacaterol ,Once daily ,business ,Baseline (configuration management) ,medicine.drug - Published
- 2010
- Full Text
- View/download PDF
50. The Effect Of Indacaterol Once-Daily On Health-Related Quality Of Life, Symptoms And Rescue Medication Use In Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Pooled Analysis Of Six Month Data
- Author
-
Benjamin Krämer, Eric C. Kleerup, Cheryl Lassen, Umit Yegen, James Williams, and Roger Owen
- Subjects
Health related quality of life ,Moderate to severe ,medicine.medical_specialty ,business.industry ,Pulmonary disease ,Rescue medication ,Pooled analysis ,Emergency medicine ,Physical therapy ,Medicine ,Indacaterol ,Once daily ,business ,medicine.drug - Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.